JEREMY PEPPER: Open Payments
NPI 1841329885 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 65 payments from 19 companies in 2025. Trend: 2023 $1,386 · 2024 $1,435 · 2025 $1,268
Food & beverage: $1,223Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $272 |
| ABBVIE INC. | 12 | $207 |
| Novo Nordisk Inc | 7 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Exact Sciences Corporation | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Paratek Pharmaceuticals, Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Amgen Inc. | 4 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: MOUNJARO, JARDIANCE, VRAYLAR, Cologuard Collection Kit, NUZYRA, Wegovy, FARXIGA, OTEZLA.
Industry payments across NC — which companies pay providers there.
